Related Experiment Video
Updated: Jul 6, 2026

Translational Rabbit Model of Chronic Cardiac Pacing
Published on: January 6, 2023
[Nicorandil-induced cutaneous ulceration on a pacemaker implantation wound]
I Jennesseaux1, D Carre-Gislard, P Bravard
1Service de dermatologie, centre hospitalier Jacques-Monod, B.P. 24, 76083 Le Havre cedex, France.
Background:
Nicorandil is a potassium-channel activator used to prevent angina. While mucosal ulceration is a well-known adverse effect of this drug, skin ulcers have been described only rarely, and always in association with mucosal ulcers.
Patients And Methods:
An 86-year-old woman presented ulceration on a pacemaker implantation scar despite complete initial wound healing. Nicorandil had been initiated three months earlier. None of the usual causes of ulceration of a pacemaker scar were seen. Complete and permanent wound-healing was achieved 12 days after discontinuation of nicorandil.
Discussion:
This is the first reported case of cutaneous ulceration on a vulnerable area of skin ascribable to high-dose nicorandil.
Related Concept Videos
Diabetic Foot Ulcer
Cardiac Catheterization IV: Nursing Management
Endocarditis IV: Nursing Management
Peripheral Artery Disease IV: Nursing Management
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Peripheral Artery Disease V: Postoperative Nursing Management
